DRUG · Mapped RxNorm record
paclitaxel
Normalized identity: paclitaxelView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
NCT00269828
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
DRUG · Unmapped registry intervention
paclitaxel poliglumex
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedA Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.
Design: INTERVENTIONAL · Status: TERMINATED · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
NSCLCverified · MONDO: non-small cell lung carcinoma
Interventions
paclitaxelDRUG · verified · RxNorm: paclitaxel
Sponsors & collaborators
CTI BioPharmalead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00269828 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.